Business Context and Reporting Period
This Form 8-K Current Report for Marchex, Inc. covers events occurring on or around May 12, 2016. The filing details the company's 2016 Annual Meeting of Stockholders, the entry into a Separation Agreement with a former executive, and updates to Board committee memberships and non-employee director compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and personnel agreements rather than financial performance metrics.
Material Changes and Corporate Actions
- Executive Separation: On May 11, 2016, Marchex entered into a Separation Agreement with Russell C. Horowitz, terminating his employment as Executive Director effective May 12, 2016. He will transition to a non-employee consultant role.
- Compensation Arrangements:
- Horowitz: Granted 100,000 restricted shares of Class B common stock (vesting quarterly through May 2017) and an annualized consulting fee of $255,000. Existing equity awards vest in full, and health benefits are covered for up to 18 months.
- Directors: On May 13, 2016, non-employee directors received an aggregate of 198,906 restricted shares and $62,000 in cash compensation.
- Board Committee Changes: Effective May 13, 2016, the Board approved changes to committee memberships, with M. Wayne Wisehart and Ian Morris designated as chairs of the Audit and Compensation committees, respectively.
Outlook, Risks, and Unusual Items
The filing does not contain forward-looking guidance, management commentary on market outlook, or specific risk factors beyond the standard legal qualifications regarding the Separation Agreement. The primary unusual item is the departure of an executive and the associated accelerated equity vesting and consulting arrangement.
Investor Verification Checklist
- Verify the total cost of the Separation Agreement, including the $255,000 annualized consulting fee and the value of the 100,000 restricted shares granted to Russell C. Horowitz.
- Confirm the vesting schedule for the 198,906 restricted shares granted to non-employee directors (100% vesting on the earlier of one year or the 2017 annual meeting).
- Review the full text of the Separation Agreement (to be filed as an exhibit in a future periodic report) for any additional covenants or conditions.
- Note the voting results from the Annual Meeting, where all director nominees were elected and the appointment of KPMG LLP was ratified.